Matthew Beutner, MD

Title(s)Assistant Professor, Pulmonology - Fresno
SchoolSchool of Medicine
AddressLocation Required, #001
Phone559-499-6400
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Saint Mary's College of CaliforniaBS2011Health Sciences
    Ross University School of MedicineMD2015Medicine
    University of California San Francisco - Fresno MEPResidency2019Internal Medicine
    University of California San Francisco - Fresno MEPFellowship2022Pulmonary and Critical Care Medicine

    Collapse Overview 
    Collapse Overview
    Matthew Beutner, MD
    Assistant Clinical Professor, UCSF
    Director, Pulmonary Hypertension Program
    Director, Pulmonary Rehabilitation Program

    Dr. Beutner specializes in Pulmonary and Critical Care Medicine and sub-specializes in Pulmonary Hypertension and Interstitial Lung Disease.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series. Pulm Circ. 2020 Apr-Jun; 10(2):2045894019898377. Balasubramanian VP, Beutner M, Gill K, Kakol M, Melendres-Groves L. PMID: 32328237; PMCID: PMC7163239.
      View in: PubMed   Mentions: 2  
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.